Item 16. Form 10-K Summary.

21K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

105 |

EXHIBITS

The exhibits listed below and designated with a † are filed with this report. The exhibits listed below and not so designated are incorporated by reference to the documents following the descriptions of the exhibits.



Exhibit 2.1		Agreement and Plan of Merger, dated as of May 15, 2018, by and among Zoetis Inc., Zeus Merger Sub, Inc. and Abaxis, Inc.
		(incorporated by reference to Exhibit 2.1 to Zoetis Inc.'s Current Report on Form 8-K filed on
		May 16, 2018 (File No. 001-35797))
Exhibit 3.1		Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to Zoetis Inc.'s Quarterly
		Report on Form 10-Q filed on November 10, 2014 (File No. 001-35797))
Exhibit 3.2		By-laws of the Registrant, amended and restated as of February 19, 2016 (incorporated by reference to Exhibit 3.2 to Zoetis
		Inc.’s 2015 Annual Report on Form 10-K filed on February 24, 2016 (File No. 001-35797))
Exhibit 4.1		Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.1 of Zoetis Inc.’s registration
		statement on Form S-1 (File No. 333-183254))
Exhibit 4.2		Indenture, dated as of January 28, 2013, between Zoetis Inc. and Deutsche Bank Trust Company Americas, as trustee
		(incorporated by reference to Zoetis Inc.'s registration statement on Form S-1 (File No. 333-183254))
Exhibit 4.3		First Supplemental Indenture, dated as of January 28, 2013, between Zoetis Inc. and Deutsche Bank Trust Company
		Americas, as trustee (incorporated by reference to Exhibit 4.3 of Zoetis Inc.'s registration statement on Form S-1
		(File No. 333-183254))
Exhibit 4.4		Second Supplemental Indenture, dated November 13, 2015, between Zoetis Inc. and Deutsche Bank Trust Company
		Americas, as trustee (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K filed on
		November 13, 2015 (File No. 001-35797))
Exhibit 4.5		Third Supplemental Indenture, dated September 12, 2017, between Zoetis Inc. and Deutsche Bank Trust Company Americas,
		as trustee (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K filed on September 12, 2017
		(File No. 001-35797))
Exhibit 4.6		Fourth Supplemental Indenture, dated August 20, 2018, between Zoetis Inc. and Deutsche Bank Trust Company Americas,
		as trustee (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K filed on August 20, 2018
		(File No. 001-35797))
Exhibit 4.7		Form of 3.450% Senior Notes due 2020 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on
		Form 8-K filed on November 13, 2015 (File No. 001-35797))
Exhibit 4.8		Form of 3.250% Senior Notes due 2023 (incorporated by reference to Exhibit 4.3 of Zoetis Inc.'s registration statement on
		Form S-1 (File No. 333-183254))
Exhibit 4.9		Form of 4.500% Senior Notes due 2025 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on
		Form 8-K filed on November 13, 2015 (File No. 001-35797))
Exhibit 4.10		Form of 4.700% Senior Notes due 2043 (incorporated by reference to Exhibit 4.3 of Zoetis Inc.'s registration statement on
		Form S-1 (File No. 333-183254))
Exhibit 4.11		Form of 3.000% Senior Notes due 2027 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K
		filed on September 12, 2017 (File No. 001-35797))
Exhibit 4.12		Form of 3.950% Senior Notes due 2027 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K
		filed on September 12, 2017 (File No. 001-35797))
Exhibit 4.13		Form of Floating Rate Senior Notes due 2021 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form
		8-K filed on August 20, 2018 (File No. 001-35797))
Exhibit 4.14		Form of 3.250% Senior Notes due 2021 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K
		filed on August 20, 2018 (File No. 001-35797))
Exhibit 4.15		Form of 3.900% Senior Notes due 2028 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K
		filed on August 20, 2018 (File No. 001-35797))
Exhibit 4.16		Form of 4.450% Senior Notes due 2048 (incorporated by reference to Exhibit 4.2 to Zoetis Inc.’s Current Report on Form 8-K
		filed on August 20, 2018 (File No. 001-35797))
Exhibit 4.17		Description of the Registrant’s Securities†

106 |



Exhibit 10.1		Global Separation Agreement, dated February 6, 2013, by and between Zoetis Inc. and Pfizer Inc. (incorporated by reference to
		Exhibit 10.1 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on March 28, 2013 (File No. 001-35797))
Exhibit 10.2		Tax Matters Agreement, dated February 6, 2013, by and between Zoetis Inc. and Pfizer Inc. (incorporated by reference to
		Exhibit 10.3 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on March 28, 2013 (File No. 001-35797))
Exhibit 10.3		Research and Development Collaboration and License Agreement, dated February 6, 2013, by and between Zoetis Inc.
		and Pfizer Inc. (incorporated by reference to Exhibit 10.4 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on
		March 28, 2013 (File No. 001-35797))
Exhibit 10.4		Pfizer Inc. 2004 Stock Plan, as Amended and Restated (incorporated by reference to Exhibit 10.6 of Zoetis Inc.'s registration
		statement on Form S-1 (File No. 333-183254))*
Exhibit 10.5		Patent and Know-How License Agreement (Zoetis as licensor), dated February 6, 2013, by and between Zoetis Inc. and
		Pfizer Inc. (incorporated by reference to Exhibit 10.8 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on
		March 28, 2013 (File No. 001-35797))
Exhibit 10.6		Patent and Know-How License Agreement (Pfizer as licensor), dated February 6, 2013, by and between Zoetis Inc. and
		Pfizer Inc. (incorporated by reference to Exhibit 10.9 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on
		March 28, 2013 (File No. 001-35797))
Exhibit 10.7		Trademark and Copyright License Agreement, dated February 6, 2013, by and between Zoetis Inc. and Pfizer Inc.
		(incorporated by reference to Exhibit 10.10 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on March 28, 2013
		(File No. 001-35797))
Exhibit 10.8		Environmental Matters Agreement, dated February 6, 2013, by and between Zoetis Inc. and Pfizer Inc. (incorporated by
		reference to Exhibit 10.13 to Zoetis Inc.’s 2012 Annual Report on Form 10-K filed on March 28, 2013) (File No. 001-35797))
Exhibit 10.9		Zoetis Inc. 2013 Equity and Incentive Plan (incorporated by reference to Exhibit 10.16 to Zoetis Inc.’s 2012 Annual Report
		on Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.10		Sale of Business Severance Plan (incorporated by reference to Exhibit 10.17 to Zoetis Inc.’s 2012 Annual Report on
		Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.11		Revolving Credit Agreement, dated as of December 21, 2016, among Zoetis Inc., the lenders party thereto and JPMorgan
		Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.1 of Zoetis Inc.'s Current Report
		on Form 8-K filed on December 21, 2016 (File No. 001-35797))
Exhibit 10.11.1		Extension Agreement to Revolving Credit Agreement, dated as of December 21, 2017, among Zoetis Inc., the lenders party
		thereto and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.16.1 to Zoetis
		Inc.’s 2017 Annual Report on Form 10-K filed on February 15, 2018 (File No. 001-35797))
Exhibit 10.11.2		Extension Agreement to Revolving Credit Agreement, dated as of December 21, 2018, among Zoetis Inc., the lenders party
		thereto and JPMorgan Chase Bank, N.A., as administrative agent†
Exhibit 10.12		Form of Indemnification Agreement for directors and officers (incorporated by reference to Exhibit 10.19 of Zoetis Inc.'s
		registration statement on Form S-1 (File No. 333-183254))
Exhibit 10.13		Form of Restricted Stock Unit Award agreement (incorporated by reference to Exhibit 10.21 to Zoetis Inc.’s 2012 Annual
		Report on Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.14		Form of Stock Option Award agreement (incorporated by reference to Exhibit 10.22 to Zoetis Inc.’s 2012 Annual Report
		on Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.15		Form of Non-Employee Director Deferred Stock Unit Award agreement (incorporated by reference to Exhibit 10.23
		on Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.16		Form of Cash Award agreement (incorporated by reference to Exhibit 10.24 to Zoetis Inc.’s 2012 Annual Report on
		Form 10-K filed on March 28, 2013 (File No. 001-35797))*
Exhibit 10.17		Form of Performance Restricted Stock Unit Award Agreement, effective as of February 27, 2015 (incorporated by
		reference to Exhibit 99.1 to Zoetis Inc.’s Current Report on Form 8-K filed on March 4, 2015 (File No. 001-35797))*
Exhibit 10.18		Form of Restricted Stock Unit Award Agreement, effective as of February 27, 2015 (incorporated by reference to
		Exhibit 99.2 to Zoetis Inc.’s Current Report on Form 8-K filed on March 4, 2015 (File No. 001-35797))*
Exhibit 10.19		Form of Stock Option Award Agreement, effective as of February 27, 2015 (incorporated by reference to Exhibit 99.3
		to Zoetis Inc.’s Current Report on Form 8-K filed on March 4, 2015 (File No. 001-35797))*
Exhibit 10.20		Form of Cash Award Agreement, effective as of February 27, 2015 (incorporated by reference to Exhibit 99.4 to

107 |



		Zoetis Inc.’s Current Report on Form 8-K filed on March 4, 2015 (File No. 001-35797))*
Exhibit 10.21		Zoetis Amended and Restated Non-Employee Director Deferred Compensation Plan (incorporated by reference to
		Exhibit 10.1 to Zoetis Inc.’s Quarterly Report on Form 10-Q filed on November 1, 2018 (File No. 001-35797))*
Exhibit 10.22		Zoetis Executive Severance Plan (incorporated by reference to Exhibit 10.1 to Zoetis Inc.’s Quarterly Report on Form 10-Q
		filed on August 14, 2013 (File No. 001-35797))*
Exhibit 10.23		Zoetis Supplemental Savings Plan, as amended and restated, effective September 15, 2014 (incorporated by reference to
		Exhibit 10.4 to Zoetis Inc.'s Quarterly Report on Form 10-Q filed on November 10, 2014 (File No. 001-35797))*
Exhibit 10.24		Zoetis Equity Deferral Plan, effective November 1, 2014 (incorporated by reference to Exhibit 10.5 to Zoetis Inc.’s
		Quarterly Report on Form 10-Q filed on November 10, 2014 (File No. 001-35797))*
Exhibit 10.25		Letter Agreement dated as of October 2, 2019, by and between Juan Ramón Alaix and Zoetis Inc. (incorporated by
		reference to Exhibit 10.1 to Zoetis Inc.'s Current Report on Form 8-K filed on October 3, 2019 (File No. 001-35797))
Exhibit 10.26		Letter Agreement dated as of December 9, 2019, by and between Clinton A. Lewis, Jr. and Zoetis Inc. (incorporated by
		reference to Exhibit 10.1 to Zoetis Inc.'s Current Report on Form 8-K filed on December 12, 2019 (File No. 001-35797))
Exhibit 21.1		Subsidiaries of the Registrant †
Exhibit 23.1		Consent of KPMG LLP †
Exhibit 24.1		Power of Attorney (included as part of signature page) †
Exhibit 31.1		Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 †
Exhibit 31.2		Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 †
Exhibit 32.1		Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
		Sarbanes-Oxley Act of 2002 † †
Exhibit 32.2		Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
		Sarbanes-Oxley Act of 2002 ††
EX-101.INS		Inline XBRL INSTANCE DOCUMENT
EX-101.SCH		Inline XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL		Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.LAB		Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE		Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EX-101.DEF		Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)



†	Filed herewith
††	Furnished herewith
*	Management contracts or compensatory plans or arrangements

108 |

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 13, 2020



Zoetis Inc.

By:	/S/ KRISTIN C. PECK
	Kristin C. Peck
	Chief Executive Officer and Director

We, the undersigned directors and officers of Zoetis Inc., hereby severally constitute Kristen C. Peck and Heidi Chen, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, in our names in the capacities indicated below, any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Under the requirements of the Securities Exchange Act of 1934, this report was signed by the following persons on behalf of the Registrant and in the capacities and on the date indicated.



Name		Title	Date

/S/ KRISTIN C. PECK		Chief Executive Officer and Director	February 13, 2020
Kristin C. Peck	(Principal Executive Officer)

/S/ GLENN DAVID		Executive Vice President and	February 13, 2020
Glenn David	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

/S/ MICHAEL B. MCCALLISTER		Chairman and Director	February 13, 2020
Michael B. McCallister

/S/ JUAN RAMÓN ALAIX		Director	February 13, 2020
Juan Ramón Alaix

/S/ PAUL M. BISARO		Director	February 13, 2020
Paul M. Bisaro

/S/ FRANK A. D'AMELIO		Director	February 13, 2020
Frank A. D’Amelio

/S/ SANJAY KHOSLA		Director	February 13, 2020
Sanjay Khosla

/s/ GREGORY NORDEN		Director	February 13, 2020
Gregory Norden

/S/ LOUISE M. PARENT		Director	February 13, 2020
Louise M. Parent

/S/ WILLIE M. REED		Director	February 13, 2020
Willie M. Reed

/S/ LINDA RHODES		Director	February 13, 2020
Linda Rhodes

/s/ ROBERT W. SCULLY		Director	February 13, 2020
Robert W. Scully

/S/ WILLIAM C. STEERE, JR.		Director	February 13, 2020
William C. Steere, Jr.

109 |

Previous: Item 15. Exhibits, Financial Statement Schedules.